BUSINESS NEWS
Big Companies Quietly Pursue Research on Embryonic Stem Cells
Stepping gingerly into a politically charged arena for the first time, some large companies in the U.S. are pursuing plans to study stem cells drawn from early-stage human embryos.
Article
Abiogen Pharma’s New Cell Therapy Starts a Clinical Phase I-II in Peritoneal Carcinosis
Article
Avigen Faces Tough Task of Selling Switch to New Field
It took Alameda’s Avigen Inc. 13 years to give up on its gene therapy business.
Article
Antibodies by Design, JPT Announce Cooperation Agreement
Antibodies by Design, a division of MorphoSys, and JPT Peptide Technologies, a wholly owned subsidiary of Jerini, announced the start of a co-marketing agreement between the two specialist companies.
Article
Bioengineered Wound Care Products Providing Caregivers with Powerful Options; Greystone Associates Assesses Impact on Wound Management Market
The introduction of new technologies and products for the treatment of acute and chronic wounds is providing caregivers with a set of powerful options that will have a profound effect on the field of wound management. These new treatment tools, which mimic the body’s natural physiology and/or regenerative pathways, include tissue-engineered skin substitutes, regeneration matrices, and biologically active cellular therapies.
Article
Trp-p8 Agonists Significantly Inhibit Growth of Trp-p8 Expressing Tumors In Vivo
Dendreon Corporation today announced the presentation of preclinical data showing that modulation of the Trp-p8 tumor target with small molecules may represent a new approach to cancer therapy.
Article
ImmunoGen, Inc. Reports Data at AACR on the Company’s HuC242-DM4 Anticancer Compound
Article
Geron Corporation Announces Multiple Presentations on Its Telomerase Inhibitor Drug GRN163L at the AACR 2005 Annual Meeting
Article
RheoGene Inc. and TissueGene Inc. Sign Collaborative Agreement for Bone Regeneration and Repair
RheoGene Inc. and TissueGene Inc. have entered into a collaborative research and licensing agreement to develop regulated cell therapy treatments for bone restoration and repair.
Article
Stem Cell Therapy International Sponsors Tech Council of Maryland’s ‘The Business of Stem Cell Research Conference’
Article
Tissue Engineering and Cell Therapy Showing Proof-of-Concept, Encouraging Continued Investment and Acquisition, According to New Report from MedMarket Diligence, LLC
Article
Pall Presents Technologies to Streamline Viral and Cancer Vaccine Production at World Vaccine Congress
Article
PharmaStem Enters into a Patent License Agreement with the University of Texas M. D. Anderson Cancer Center
PharmaStem Therapeutics, Inc. announced today that it has entered into an agreement under which The University of Texas M. D. Anderson Cancer Center has obtained a license to PharmaStem’s patent portfolio for the storage and use of umbilical cord blood.
Article
MARKET REPORTS
Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy, and Immunotherapeutic approaches to Cancer.
“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information, including order forms, please see:
Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1 Vol. 2
Cell Therapy Order Form
“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:
Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form
The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.
A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents
Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents
Immunotherapy Reports Order Form